Therapeutics II Top 200 - Endocrinology, Cardiovascular/Renal, Dermatology, Respiratory

Home

Get App

Create

glimepiride

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
- 1. Amaryl
- 2. 2nd generation sulfonylurea
- 3. Type II Diabetes Mellitus
- 4. inhibit ATP-K+ channels in pancreas, causing Ca2+ channel activation/influx that releases insulin
- 5. 1-2 mg once daily; 8mg per day, max dose
- 6. ACEi, Beta- Blockers, Fluoroquinolones
glipizide IR, ER

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
- 1.
- 2.
- 3.
- 4.
- 5.
- 6.
glyburide IR

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
- 1.
- 2.
- 3.
- 4.
- 5.
- 6.
insulin glargine

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
- 1.
- 2.
- 3.
- 4.
- 5.
- 6.
levothyroxine

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
- 1.
- 2.
- 3.
- 4.
- 5.
- 6.
metformin IR, ER

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
- 1.
- 2.
- 3.
- 4.
- 5.
- 6.
phentermine

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
- 1.
- 2.
- 3.
- 4.
- 5.
- 6.
sitagliptan

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
- 1.
- 2.
- 3.
- 4.
- 5.
- 6.
amlodipine

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
- 1.
- 2.
- 3.
- 4.
- 5.
- 6.
amlodipine/benazepril

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
- 1.
- 2.
- 3.
- 4.
- 5.
- 6.
aspirin

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
- 1.
- 2.
- 3.
- 4.
- 5.
- 6.
atenolol

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
- 1.
- 2.
- 3.
- 4.
- 5.
- 6.
atorvastatin

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
- 1.
- 2.
- 3.
- 4.
- 5.
- 6.
benazepril

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
- 1.
- 2.
- 3.
- 4.
- 5.
- 6.
carvedilol IR

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
- 1.
- 2.
- 3.
- 4.
- 5.
- 6.
clonidine

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
- 1.
- 2.
- 3.
- 4.
- 5.
- 6.
clopidogrel

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
- 1.
- 2.
- 3.
- 4.
- 5.
- 6.
diltiazem

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
- 1.
- 2.
- 3.
- 4.
- 5.
- 6.
enalapril

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
enoxaparin

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
ezetimibe

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
fenofibrate/fenofibric acid

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
folic acid

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
furosemide

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
heparin

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
hydralazine

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
hydrochlorothiazide

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
isosorbide mononitrate

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
lisinopril

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
lisinopril/hydrochlorothiazide

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
losartan

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
losartan/hydrochlorothiazide

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
lovastatin

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
metoprolol succinate

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
metoprolol tartrate

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
nebivolol

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
potassium chloride

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
pravastatin

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
propranolol LA/XL

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
ramipril

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
rivaroxaban

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
rosuvastatin

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
simvastatin

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
spironolactone

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
triamterene/hydrochlorothiazide

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
valsartan

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
valsartan/HCTZ

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
warfarin

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
albuterol HFA

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
benzonatate

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
cetirizine

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
dextromethorphan

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
diphenhydramine

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
fluticasone HFA

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
fluticasone propionate

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
fluticasone/salmeterol Diskus

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
formoterol/budesonide

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
guaifensen IR, ER

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
ketotifen

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
loratadine

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
mometasone

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
montelukast

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
oxymetazoline

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
phenylephrine

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
pseudoephedrine

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
tiotropium Handihaler

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
triamcinolone nasal

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
clobetasol

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
hydrocortisone

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
hydroxyzine HCl

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
miconazole

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
nystatin

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
terbinafine

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI
triamcinolone topical

1. Brand
2. Class
3. Indication
4. MOA
5. Dose
6. ADR/ADE/Major DDI

Author

mbailey585

326459

Card Set

Therapeutics II Top 200 - Endocrinology, Cardiovascular/Renal, Dermatology, Respiratory

Description

Therapeutics II Top 200 - Endocrinology, Cardiovascular/Renal, Dermatology, Respiratory

Updated

2016-12-03T15:20:15Z

Show Answers